Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence.

​​ Tardive dyskinesia (TD) is a condition of potentially irreversible abnormal involuntary movements associated with dopamine receptor blocking agents, such as antipsychotics. While prevention is the best strategy, it is not always possible. This report outlines strategies to reduce TD symptoms, including the use of the FDA-approved treatment options (valbenazine and deutetrabenazine). © Copyright 2020 Physicians Postgraduate Press, Inc.

Citation

Joseph P McEvoy. Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence. The Journal of clinical psychiatry. 2020 Sep 29;81(6)

Mesh Tags

Substances

PMID: 32991793

search → result